OSHA, The Bloodborne Pathogens Standard, and You William J. Duffy, RN, MJ, CNOR
- Most frequently asked questions concerning the bloodborne pathogen standard. OSHA Standards Interpretation and Compliance Letters. February 1, 1993. www.osha.gov/OshDoc/Interp, p. 1.
- OSHA revises bloodborne pathogens compliance directive. OSHA National News Release. November 5, 1999. www.osha.gover/media/oshnews/nov99/national, p. 1.
- Most frequently asked questions concerning the bloodborne pathogen standard. OSHA Standards Interpretation and Compliance Letters. February 1, 1993. www.osha.gov/OshDoc/Directive, p. 8.
- Enforcement procedures for the occupational exposure to bloodborne pathogens. OSHA Directive CPL 2-2.44D. November 5, 1999. www.osha/gov/OshDoc/Directive, p. 8
- Annual training required by the occupational exposure to bloodborne pathogens standard. OHSA Standards Interpretation and Compliance Letters. August 31, 1997. www.osha.gov/OshDoc/Interp, p.1.
- Enforcement procedures for the occupational exposure to bloodborne pathogens. p. 43.
- Occupational exposure to bloodborne pathogens, 29 CFR 1910.1030 (g)(2)(vii)(A-L).
- 29 CFR 1910.1030 (g)(2)(vii)(M-N)-(g)(2)(viii).
- Most frequently asked questions concerning the bloodborne pathogens standard. OSHA Standards Interpretation and Compliance Letters. February 1, 1993. www.osha.gov/OshDoc/Interp.
- American Dental Association v. Martin, 984 F.2d823 (1993).
- Enforcement procedures for the occupational exposure to bloodborne pathogens. p. 7.
- Record summary of the request for information on occupational exposure to bloodborne pathogens due to percutaneous injury. May 20, 1999. www.osha.gov/num/ndireport. p. 8.
- Blood safety survey shows room for improvement. OR Manager. November 1999;15(11):9.
- Jagger J, et al. A study of patterns ad prevention of blood exposure in OR personnel. AORN J. May 1998;67:979-995.
- Enforcement procedures for the occupational exposure to bloodborne pathogen. P. 11.
- Record summary of the request for information on occupational exposure to bloodborne pathogens due to percutaneous injury. May 20, 1999. www.osha.gov/num/ndireport. p. 2.
- Enforcement procedures for the occupational exposure to bloodborne pathogens. p. 15.
Hepatitis C, Not Your Average Virus By Charlene Buckner, RN, CIC, COHN-S, and Ann Drake, RN, CIC
- CDC. Recommendations for Prevention and Control of Hepatitis C Virus (HCV) Infection and HCV-Related Chronic Disease. MMWR. 47(RR-19).
- NIH. Management of Hepatitis C. 1997 March. 24-26;15(3):1-41.
- Goodman T. Control of infections related to bloodborne pathogens. Infect Control Today. 2000(4);6:24-28
Cleaning & Disinfecting
Safety First: Read, Heed Labels By Janet B. Kreizman
- Consumer Product Safety Commission, Federal Hazards Substances Act, 16CFR1500.121 (Code of Federal Regulation).
- Occupational Safety and Health Administration Regulations, Hazard Communications, Toxic, and Hazardous Substances, 29CFR1910.1200.
Technology vs. the Most Common Nosocomial Infection By Sandra K. Watson, RN, BSN, CIC; Deborah Ann Lictengberg, RN, BSN, CIC; and Holly Wainwright, RN, BSN, MBA, CIC
- William JR. Chief, Investigation and Prevention Branch Hospital Infections Program, CDC, Atlanta on March 5, 2000 at the 4th Decennial International Conference on Nosocomial and Healthcare-Associated Infections.
- Weinstein RA, Nosocomial infection update. Emerging Infectious Diseases. 1998;4(3): 416-120.
- Garibaldi RA. Hospital-Acquired Urinary Tract Infections. In: Wenzel RP ed. Prevention and Control of Nosocomial Infections. 2nd ed. Baltimore: Williams & Wilkins. 1993;600-13.
- IcanNews & Commentary. Conference Coverage. Silver-coated catheter helps prevent urinary tract infections. Updated March 10, 2000.
- Bologna RA, Tu LM, Polansky HD, et al: Hydrogel/silver ion-coated urinary catheter reduces nosocomial urinary tract infection rates in intensive care unit patients: a multicenter study. Adult Urology. 54:982-987.
- Maki DG, Knasinski V, Tambyah PA. Abstract: Risk factors for
A prospective study showing the minimal impact of catheter care violations on the risk of CAUTI. 4th Decennial International Conference on Nosocomial and Healthcare-Associated Infections, Atlanta, Georgia. March 2000.
- Saint, S. Clinical and economic consequences of nosocomial catheter-related bacteriuria. American Journal of Infection Control. February 2000;8(1):68-75.
- Centers for Disease Control. Public Health Focus: Surveillance, Prevention, and Control of Nosocomial infections. MMWR 1992;41:783-787.
- Classen, DC. Assessing the effect of adverse hospital events on the cost of hospitalization and other patient outcomes. (Thesis). Salt Lake City, Utah: University of Utah, 1993.
- Burk JP, Zavasky D-M. Nosocomial urinary tract infections. In: C. Glen Mayhall ed. Hospital Epidemiology and Infection Control. Lippincott Williams & Wikins. Philadelphia 1999.
- Carr HA. Short history of the foley catheter: from handmade instrument to infection-prevention device. J Endourology. February 2000;14(1):5-8.
- Carr HA. Catheter-associated urinary tract infections in adults: prevention through care and technology. Infection Control Today. August 1998;2:8.
- Bruce AW, et al. Urethral response to latex and silastic catheter. Can Med Assoc J. 1976;115:1099-1100.
- Thomas LL. Urinary tract infections related to catheterization. ICST. February 1999:27, 38.
- Riley DK, Classen DC, Stevens LE, et al. A large randomized clinical trial of a silver-impregnated urinary catheter: lack of efficacy and staphylococcal superinfection. Am J Med. 1995;177(4):349-56.
- Wright BJ. Wound Management in an era of increasing bacterial antibiotic resistance: A role for topical silver treatment. AJIC. 1998;26(6):572-577.
- Saint S, Elmore JG, Sullivan SD, et al. The efficacy of silver alloy-coated urinary catheters in preventing urinary tract infection: a meta-analysis. Am L of Med. September 1998;105:236-241.
- Saint, S, et al. (Abstract) The clinical and economic effects of silver alloy urinary catheters to prevent urinary tract infection. AJIC. April 1999;27(2):186.
- Lettau, L, et al. (Abstract) Silver hydrogel-coated urinary catheters for the prevention on nosocomial urinary tract infections (NUTI): a collaborative study in Nine community hospitals. Presented at IDSA. November 1998.
- Maki DG, Knasinski V, Tambyah PA. Abstract: A Prospective investigator-blinded Trial of a novel nitrofurazone-impregnated indwelling urinary catheter. SHEA 1997.
- Leclair JM, et al. (Abstract) Effect of a nirtofurazone-impregnated urinary catheter on the incidence of catheter-associated UTI in burn patients.
- Release-NF Instructions For Use Product Insert Sheet. Rochester Medical, One Rochester Medical Drive, Stewartville, MN 55976.
- Anti-infective process patented. Hospital Purchasing News. 1999:1-12.
- Hoekstra D. Hyaluronan-modified surfaces for medical devices. Medical Device & Diagnostic Industry. 1999:48-51.
- Pugliese G, Favero MS. Medical news. Infect Control Hosp Epidemiol. 1999;20:368.